Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading update

15 Jan 2008 07:00

BrainJuicer Group PLC15 January 2008 Press Release 15 January 2008 BrainJuicer Group PLC ("BrainJuicer" or "the Company") Trading update BrainJuicer Group PLC, (AIM: BJU), a leading international online marketresearch agency, today updates the market on trading. The Board is pleased toannounce that for the financial year ended 31 December 2007, both revenue andprofitability were comfortably ahead of market expectations. A detailedbusiness update will be provided at the Preliminary Results in March. - Ends - For further information, please contact: BrainJuicer plcJohn Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000 www.brainjuicer.com Landsbanki Securities (UK) LimitedNomad & BrokerFred Walsh / Simon Brown Tel: +44 (0)20 7426 9000 www.landsbanki.co.uk Media enquiries: Abchurch CommunicationsHeather Salmond / Joanne Shears Tel: +44 (0) 20 7398 7700joanne.shears@abchurch-group.com www.abchurch-group.com Notes to Editors: BrainJuicer carries out quantitative online research using innovative, bespokesoftware to produce insightful market research for large, multinationalcompanies, including 10 of the world's top 50 companies (FT 500 September 2006). BrainJuicer operates in a growing sector of the US$25bn global research market,namely quantitative online research. BrainJuicer's main competitors are largetraditional market research providers who have dominated the market for off-linemarket research, such as AC Nielsen, Millward Brown, Research International andTaylor Nelson Sofres. Whilst the largest traditional research companies have developed their ownonline capability, BrainJuicer has a number of key attributes which havecontributed to it achieving rapid growth and winning contracts with prestigiousclients, including: • Research platform that delivers greater diagnostic insight. BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level of diagnostic insight into quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services. • Speed. BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services. • A scaleable online-only business model. Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model. To date the Group has conducted projects in over 50 countries and more than 30languages and has established offices in the UK, the Netherlands and the US. The Group's revenues come from full service market research work, and from itsonline Juicy Brains Panel in the UK. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.